HIV-1 GENOTYPING ASSAY FOR GLOBAL SURVEILLANCE OF HIV-1 DRUG RESISTANCE
    2.
    发明申请
    HIV-1 GENOTYPING ASSAY FOR GLOBAL SURVEILLANCE OF HIV-1 DRUG RESISTANCE 有权
    HIV-1耐药性全球监测的HIV-1基因分析

    公开(公告)号:US20140106340A1

    公开(公告)日:2014-04-17

    申请号:US14125564

    申请日:2012-07-05

    IPC分类号: C12Q1/70

    摘要: Provided herein are new methods, primers, and kits for genotyping HIV-1, including group M viral strains. The methods can be used for HIV-1 drug resistance surveillance and monitoring, for example in resource-poor countries. The disclosed methods can detected more mixed HIV-1 population than previous methods. Given the high efficiency in genotyping diverse HIV-1 group M viral strains from plasma and dried blood spot (DBS) samples and substantial reagent cost saving, the disclosed methods can be used for HIV-1 drug resistance genotyping in both antiretroviral therapy (ART)-naive and -experienced populations for surveillance purposes and patient monitoring.

    摘要翻译: 本文提供了用于基因分型HIV-1(包括M组病毒株)的新方法,引物和试剂盒。 这些方法可用于HIV-1耐药性监测和监测,例如资源贫乏国家。 所公开的方法可以检测到比以前的方法更多的混合的HIV-1群体。 鉴于来自血浆和干血斑(DBS)样品的多种HIV-1组M病毒株的基因分型的高效率和显着的试剂成本节省,所公开的方法可用于抗逆转录病毒治疗(ART)中的HIV-1耐药性基因分型 - 有经验和经验的人群进行监视和患者监测。

    Methods and reagents for molecular detection of HIV-1 groups M, N and O
    3.
    发明授权
    Methods and reagents for molecular detection of HIV-1 groups M, N and O 有权
    用于分子检测HIV-1组M,N和O的方法和试剂

    公开(公告)号:US08575324B2

    公开(公告)日:2013-11-05

    申请号:US11645988

    申请日:2006-12-27

    摘要: Reagents and assays for detecting HIV-1 groups M and O and optionally HIV-1 group N and SIVcpz are provided. The reagents are nucleic acid primers for the hybridization to, amplification and subsequent detection of HIV-1 groups M, N and O and SIVcpz in a biological sample. The primers are oligonucleotides that selectively hybridize to the highly conserved regions of the env and pol regions of HIV-1. Due to the high sensitivity of the assays, small concentrations of HIV in a biological sample can be detected, allowing diagnosis at an early stage of infection. The assays are qualitative or quantitative and are useful for viral load determinations of HIV-1 groups M, N or O in a patient undergoing treatment for HIV-1 infection. Viral load determinations can be used to monitor the progress of the treatment regimen, the development of drug resistance, and to predict disease progression.

    摘要翻译: 提供了用于检测HIV-1组M和O以及任选的HIV-1组N和SIVcpz的试剂和测定法。 试剂是用于杂交,扩增和随后检测生物样品中HIV-1组M,N和O和SIVcpz的核酸引物。 引物是与HIV-1的env和pol区域的高度保守区域选择性杂交的寡核苷酸。 由于测定的高灵敏度,可以检测生物样品中的小浓度的HIV,从而允许在感染早期进行诊断。 测定是定性的或定量的,并且可用于经历HIV-1感染治疗的患者中HIV-1组M,N或O的病毒载量测定。 病毒载量测定可用于监测治疗方案的进展,耐药性的发展以及预测疾病进展。

    Methods and reagents for molecular detection of HIV-1 groups M, N and O
    4.
    发明申请
    Methods and reagents for molecular detection of HIV-1 groups M, N and O 有权
    用于分子检测HIV-1组M,N和O的方法和试剂

    公开(公告)号:US20070275372A1

    公开(公告)日:2007-11-29

    申请号:US11645988

    申请日:2006-12-27

    IPC分类号: C12Q1/70 C07H21/04

    摘要: Reagents and assays for detecting HIV-1 groups M and O and optionally HIV-1 group N and SIVcpz are provided. The reagents are nucleic acid primers for the hybridization to, amplification and subsequent detection of HIV-1 groups M, N and O and SIVcpz in a biological sample. The primers are oligonucleotides that selectively hybridize to the highly conserved regions of the env and pol regions of HIV-1. The assays employ the primers for HIV-1 nucleic acid amplification using amplification techniques such as reverse transcription and the polymerase chain reaction. The assays are useful for diagnosing an HIV-1 group M, HIV-1 group N, or an HIV-1 group O infection in a patient. Due to the high sensitivity of the assays, small concentrations of HIV in a biological sample can be detected, thereby allowing diagnosis at an early stage of infection. The assays are also useful for detecting HIV-1 contamination in a biological fluid such as blood. The assays are qualitative or quantitative and are therefore useful for viral load determinations of HIV-1 groups M, N or O in a patient undergoing treatment for HIV-1 infection. Viral load determinations can be used to monitor the progress of the treatment regimen or the development of drug resistance and can be used to predict disease progression.

    摘要翻译: 提供了用于检测HIV-1组M和O以及任选的HIV-1组N和SIVcpz的试剂和测定法。 试剂是用于杂交,扩增和随后检测生物样品中HIV-1组M,N和O和SIVcpz的核酸引物。 引物是与HIV-1的env和pol区域的高度保守区域选择性杂交的寡核苷酸。 该测定使用扩增技术如逆转录和聚合酶链反应的HIV-1核酸扩增引物。 该测定法可用于诊断患者中HIV-1组M,HIV-1组N或HIV-1组O感染。 由于测定的高灵敏度,可以检测生物样品中的小浓度的HIV,从而允许在感染早期进行诊断。 该测定法也可用于检测生物流体如血液中的HIV-1污染。 测定是定性的或定量的,因此可用于在接受HIV-1感染治疗的患者中HIV-1组M,N或O的病毒载量测定。 病毒载量测定可用于监测治疗方案的进展或耐药性的发展,并可用于预测疾病进展。

    HIV-1 genotyping assay for global surveillance of HIV-1 drug resistance
    5.
    发明授权
    HIV-1 genotyping assay for global surveillance of HIV-1 drug resistance 有权
    用于HIV-1耐药性全身监测的HIV-1基因分型测定

    公开(公告)号:US09040244B2

    公开(公告)日:2015-05-26

    申请号:US14125564

    申请日:2012-07-05

    IPC分类号: C12Q1/68 C12Q1/70

    摘要: Provided herein are new methods, primers, and kits for genotyping HIV-1, including group M viral strains. The methods can be used for HIV-1 drug resistance surveillance and monitoring, for example in resource-poor countries. The disclosed methods can detected more mixed HIV-1 population than previous methods. Given the high efficiency in genotyping diverse HIV-1 group M viral strains from plasma and dried blood spot (DBS) samples and substantial reagent cost saving, the disclosed methods can be used for HIV-1 drug resistance genotyping in both antiretroviral therapy (ART)-naive and -experienced populations for surveillance purposes and patient monitoring.

    摘要翻译: 本文提供了用于基因分型HIV-1(包括M组病毒株)的新方法,引物和试剂盒。 这些方法可用于HIV-1耐药性监测和监测,例如资源贫乏国家。 所公开的方法可以检测到比以前的方法更多的混合的HIV-1群体。 鉴于来自血浆和干血斑(DBS)样品的多种HIV-1组M病毒株的基因分型的高效率和显着的试剂成本节省,所公开的方法可用于抗逆转录病毒治疗(ART)中的HIV-1耐药性基因分型 - 有经验和经验的人群进行监视和患者监测。

    Methods and reagents for molecular detection of HIV-1 groups M, N and O
    6.
    发明申请
    Methods and reagents for molecular detection of HIV-1 groups M, N and O 审中-公开
    用于分子检测HIV-1组M,N和O的方法和试剂

    公开(公告)号:US20050142540A1

    公开(公告)日:2005-06-30

    申请号:US10980660

    申请日:2004-11-03

    摘要: Reagents and assays for detecting HIV-1 groups M and O and optionally HIV-1 group N and SIVcpz are provided. The reagents are nucleic acid primers for the hybridization to, amplification and subsequent detection of HIV-1 groups M, N and O and SIVcpz in a biological sample. The primers are oligonucleotides that selectively hybridize to the highly conserved regions of the env and pol regions of HIV-1. The assays employ the primers for HIV-1 nucleic acid amplification using amplification techniques such as reverse transcription and the polymerase chain reaction. The assays are useful for diagnosing an HIV-1 group M, HIV-1 group N, or an HIV-1 group O infection in a patient. Due to the high sensitivity of the assays, small concentrations of HIV in a biological sample can be detected, thereby allowing diagnosis at an early stage of infection. The assays are also useful for detecting HIV-1 contamination in a biological fluid such as blood. The assays are qualitative or quantitative and are therefore useful for viral load determinations of HIV-1 groups M, N or O in a patient undergoing treatment for HIV-1 infection. Viral load determinations can be used to monitor the progress of the treatment regimen or the development of drug resistance and can be used to predict disease progression.

    摘要翻译: 提供了用于检测HIV-1组M和O以及任选的HIV-1组N和SIVcpz的试剂和测定法。 试剂是用于杂交,扩增和随后检测生物样品中HIV-1组M,N和O和SIVcpz的核酸引物。 引物是与HIV-1的env和pol区域的高度保守区域选择性杂交的寡核苷酸。 该测定使用扩增技术如逆转录和聚合酶链反应的HIV-1核酸扩增引物。 该测定法可用于诊断患者中HIV-1组M,HIV-1组N或HIV-1组O感染。 由于测定的高灵敏度,可以检测生物样品中的小浓度的HIV,从而允许在感染早期进行诊断。 该测定法也可用于检测生物流体如血液中的HIV-1污染。 测定是定性的或定量的,因此可用于HIV-1感染治疗的患者中HIV-1组M,N或O的病毒载量测定。 病毒载量测定可用于监测治疗方案的进展或耐药性的发展,并可用于预测疾病进展。